Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00321204
Status:
TERMINATED
Last Update Posted:
2014-04-23
First Post:
2006-05-01
Brief Title:
A Retrospective Study of the Role of Thiazolidinediones to Reduce the Incidence of Atrial Arrhythmias
Sponsor:
Emory University
Organization:
Emory University
Study Overview
Official Title:
A Retrospective Study of the Role of Thiazolidinediones to Reduce the Incidence of Atrial Arrhythmias in Patients After Cardiac Surgery
Status:
TERMINATED
Status Verified Date:
2014-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Terminated We are no longer recruiting
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
It is well known that abnormal heart beats from the top parts of the heart atrial fibrillation AF and atrial flutter Aflut occur frequently after most types of cardiac surgeries Postoperative AF and Aflut are associated with significant morbidity longer hospital stay and higher related costs Currently therapies are marginally effective at preventing this abnormal heart beat The incidence of abnormal heart beats after cardiac surgery seems to be a function of the amount of inflammation and oxidative stress induced Our group and others have shown that atrial abnormal heart beats are associated with increased oxidative stress Thiazolidinediones TZDs are medications used to treat diabetes Beside their glucose lowering effects TZDs are shown to exhibit anti-inflammatory and antioxidant properties Therefore we propose to retrospectively analyze the effect of pre-operative TZDs on the incidence of post-operative AF or Aflut This study will involve retrospective chart reviews without further patient contact of all patients having undergone cardiac surgery in Emory University Hospital Crawford Long Hospital or the VA Medical Center from 2000 to 2005 This study is preparatory to a funding proposal for a prospective trial
Detailed Description:
10 Background
Cardiac surgery is associated with many perioperative complications including supraventricular arrhythmias1-4 Atrial fibrillation occurs in 15 to 40 of patients after coronary artery bypass grafting CABG and up to 60 after CABG and valve repair It can lead to significant complications such as stroke prolonged hospitalizations increasing mortality and morbidity15
Post-operative atrial arrhythmias seem to be related to the degree of inflammation and oxidative stress induced during surgery2-4 Our group and others have shown that atrial arrhythmias are associated with increased oxidative stress6-10 Moreover increased oxidative stress associated with angiotensin II-mediated NADPH oxidase activation leads to electrical abnormalities likely to propagate arrhythmias1112
Thiazolidinediones TZDs are antidiabetic agents that enhance insulin sensitivity through activating peroxisome proliferators-activated receptor PPAR gamma Beside their glucose lowering effects TZDs are shown to exhibit anti-inflammatory and antioxidant properties13-17
20 Objectives
Based on the discussion above we hypothesize that pre-operative use of TZDs will decrease post-operative AF or Aflut incidence This study will be a retrospective cohort analysis of all patients that underwent elective cardiac surgeries between 2000-2005 at Emory University Hospital Crawford Long Hospital or the Atlanta Veterans Affairs Medical Center to evaluate the relationship of pre-operative TZD use to the incidence of post-operative atrial arrhythmias This study is undertaken in preparation for a funding proposal for a prospective trial
30 Patient Selection
31 Eligibility criteria
1 All patients that patients who underwent elective cardiac surgery in the Emory University Hospital Crawford Long Hospital or the VA Medical Center between 2000-2005
32 Ineligibility criteria
1 Emergent operations
2 The presence of AF or Aflut at the time of surgery
3 Patients without adequate documentation of atrial rhythm following surgery
4 New York Heart Association NYHA class IV heart failure at the time of surgery
5 Hyperthyroidism
6 Implanted devices for designed for active management of atrial arrhythmias by pacing or defibrillation
7 Known illicit drug use
8 Known ethanol abuse
9 Electrophysiological ablation for atrial tachycardia within 6 months of the operation
40 Registration and randomization none
50 Therapy none
60 Pathology none
70 Patient assessment none
80 Data collection Data will be collected from review of the patients hospital charts from telemetry recordings and ECGs to document the presence or absence of AF or Aflut during the hospital admission for cardiac surgery The presence or absence of atrial fibrillation will be diagnosed on the basis of an electrocardiographic recording and confirmed by a cardiologist Demographic data collected will include age race sex body mass index blood pressure NYHA classification Killip classification and the history of previous myocardial infarction hypertension diabetes smoking alcohol use antiarrhythmic drug use presence and type of pacemaker if any history of AF or Aflut previous cardioversions type of operation and length of operation Patients enrolled in this study will be given unique study numbers No follow up data will be required from patients
90 Statistical considerations This study design is a retrospective chart review of a cohort of patients undergoing cardiac surgery to determine if there is an association between pre-operative TZD use and the incidence of post-operative atrial fibrillation or Aflut The null hypothesis is that there is no association between the preoperative use of TZDs and postoperative AF and Aflut Within the cohort those patients with AF or Aflut will be compared to those without these atrial arrhythmias in the post-operative period Baseline data for the two groups will be expressed as mean standard deviation for continuous variables and frequencies for categorical variables Differences in baseline characteristics between the groups will be examined by use of Fisher exact and Mann-Whitney tests for categorical and continuous variables respectively Quantification of any association between pre-operative TZD and the presence of atrial fibrillation will modeled by logistical regression analysis after adjusting for other variables that may affect arrhythmia frequency
Cardiac surgery is associated with many perioperative complications including supraventricular arrhythmias1-4 Atrial fibrillation occurs in 15 to 40 of patients after coronary artery bypass grafting CABG and up to 60 after CABG and valve repair It can lead to significant complications such as stroke prolonged hospitalizations increasing mortality and morbidity15
Post-operative atrial arrhythmias seem to be related to the degree of inflammation and oxidative stress induced during surgery2-4 Our group and others have shown that atrial arrhythmias are associated with increased oxidative stress6-10 Moreover increased oxidative stress associated with angiotensin II-mediated NADPH oxidase activation leads to electrical abnormalities likely to propagate arrhythmias1112
Thiazolidinediones TZDs are antidiabetic agents that enhance insulin sensitivity through activating peroxisome proliferators-activated receptor PPAR gamma Beside their glucose lowering effects TZDs are shown to exhibit anti-inflammatory and antioxidant properties13-17
20 Objectives
Based on the discussion above we hypothesize that pre-operative use of TZDs will decrease post-operative AF or Aflut incidence This study will be a retrospective cohort analysis of all patients that underwent elective cardiac surgeries between 2000-2005 at Emory University Hospital Crawford Long Hospital or the Atlanta Veterans Affairs Medical Center to evaluate the relationship of pre-operative TZD use to the incidence of post-operative atrial arrhythmias This study is undertaken in preparation for a funding proposal for a prospective trial
30 Patient Selection
31 Eligibility criteria
1 All patients that patients who underwent elective cardiac surgery in the Emory University Hospital Crawford Long Hospital or the VA Medical Center between 2000-2005
32 Ineligibility criteria
1 Emergent operations
2 The presence of AF or Aflut at the time of surgery
3 Patients without adequate documentation of atrial rhythm following surgery
4 New York Heart Association NYHA class IV heart failure at the time of surgery
5 Hyperthyroidism
6 Implanted devices for designed for active management of atrial arrhythmias by pacing or defibrillation
7 Known illicit drug use
8 Known ethanol abuse
9 Electrophysiological ablation for atrial tachycardia within 6 months of the operation
40 Registration and randomization none
50 Therapy none
60 Pathology none
70 Patient assessment none
80 Data collection Data will be collected from review of the patients hospital charts from telemetry recordings and ECGs to document the presence or absence of AF or Aflut during the hospital admission for cardiac surgery The presence or absence of atrial fibrillation will be diagnosed on the basis of an electrocardiographic recording and confirmed by a cardiologist Demographic data collected will include age race sex body mass index blood pressure NYHA classification Killip classification and the history of previous myocardial infarction hypertension diabetes smoking alcohol use antiarrhythmic drug use presence and type of pacemaker if any history of AF or Aflut previous cardioversions type of operation and length of operation Patients enrolled in this study will be given unique study numbers No follow up data will be required from patients
90 Statistical considerations This study design is a retrospective chart review of a cohort of patients undergoing cardiac surgery to determine if there is an association between pre-operative TZD use and the incidence of post-operative atrial fibrillation or Aflut The null hypothesis is that there is no association between the preoperative use of TZDs and postoperative AF and Aflut Within the cohort those patients with AF or Aflut will be compared to those without these atrial arrhythmias in the post-operative period Baseline data for the two groups will be expressed as mean standard deviation for continuous variables and frequencies for categorical variables Differences in baseline characteristics between the groups will be examined by use of Fisher exact and Mann-Whitney tests for categorical and continuous variables respectively Quantification of any association between pre-operative TZD and the presence of atrial fibrillation will modeled by logistical regression analysis after adjusting for other variables that may affect arrhythmia frequency
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1308-2005 | OTHER | Other | None |